ProfileGDS4718 / 224842_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 96% 96% 96% 96% 97% 96% 97% 96% 97% 96% 95% 97% 97% 97% 95% 95% 96% 97% 94% 95% 95% 95% 96% 95% 96% 97% 97% 98% 96% 97% 96% 97% 97% 97% 97% 96% 96% 97% 96% 96% 96% 97% 97% 97% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.843496
GSM549102patient 115, normal, homogenized [OPG study]10.704196
GSM549104patient 119, normal, homogenized [OPG study]10.675596
GSM549108patient 138, normal, homogenized [OPG study]10.419196
GSM549119patient 077, normal, homogenized [OPG study]10.983297
GSM549133patient 032, cancer, homogenized [OPG study]10.663496
GSM549139patient 042, cancer, homogenized [OPG study]10.762197
GSM549099patient 107, normal, homogenized [OPG study]10.465296
GSM549109patient 139, normal, homogenized [OPG study]11.196897
GSM549110patient 046, normal, homogenized [OPG study]10.801796
GSM549114patient 063, normal, homogenized [OPG study]10.568695
GSM549122patient 082, normal, homogenized [OPG study]10.841597
GSM549134patient 033, cancer, homogenized [OPG study]10.764697
GSM549136patient 036, cancer, homogenized [OPG study]10.986997
GSM549140patient 044, cancer, homogenized [OPG study]10.327795
GSM549111patient 047, normal, homogenized [OPG study]10.500795
GSM549113patient 057, normal, homogenized [OPG study]10.832796
GSM549132patient 031, cancer, homogenized [OPG study]10.773397
GSM549137patient 038, cancer, homogenized [OPG study]9.9921494
GSM549142patient 047, cancer, homogenized [OPG study]9.6016995
GSM549100patient 110, normal, homogenized [OPG study]10.363195
GSM549107patient 135, normal, homogenized [OPG study]10.345795
GSM549115patient 068, normal, homogenized [OPG study]10.750696
GSM549116patient 072, normal, homogenized [OPG study]10.414795
GSM549120patient 078, normal, homogenized [OPG study]10.584696
GSM549131patient 030, cancer, homogenized [OPG study]10.762297
GSM549118patient 074, normal, homogenized [OPG study]10.966597
GSM549129patient 027, cancer, homogenized [OPG study]11.17198
GSM549123patient 088, normal, homogenized [OPG study]10.765896
GSM549124patient 006, cancer, homogenized [OPG study]10.625397
GSM549126patient 015, cancer, homogenized [OPG study]10.368296
GSM549128patient 025, cancer, homogenized [OPG study]10.674497
GSM549103patient 117, normal, homogenized [OPG study]10.909697
GSM549117patient 073, normal, homogenized [OPG study]11.043697
GSM549138patient 041, cancer, homogenized [OPG study]10.801597
GSM549141patient 045, cancer, homogenized [OPG study]10.653896
GSM549130patient 028, cancer, homogenized [OPG study]10.36796
GSM549101patient 111, normal, homogenized [OPG study]10.956497
GSM549105patient 128, normal, homogenized [OPG study]10.382896
GSM549106patient 134, normal, homogenized [OPG study]10.645896
GSM549112patient 048, normal, homogenized [OPG study]10.568796
GSM549125patient 011, cancer, homogenized [OPG study]10.992997
GSM549127patient 024, cancer, homogenized [OPG study]10.770997
GSM549135patient 035, cancer, homogenized [OPG study]10.778497